Unique ID issued by UMIN | UMIN000006624 |
---|---|
Receipt number | R000007585 |
Scientific Title | Study of the effect of modification of slow wave sleep by hypnotics on glucose tolerance in healthy male volunteers |
Date of disclosure of the study information | 2011/10/28 |
Last modified on | 2012/10/29 15:00:39 |
Study of the effect of modification of slow wave sleep by hypnotics on glucose tolerance in healthy male volunteers
Study of the effect of modification of slow wave sleep by hypnotics on glucose tolerance in healthy male volunteers
Study of the effect of modification of slow wave sleep by hypnotics on glucose tolerance in healthy male volunteers
Study of the effect of modification of slow wave sleep by hypnotics on glucose tolerance in healthy male volunteers
Japan |
healthy male volunteers
Not applicable | Adult |
Others
NO
To examine the effect of triazolam and zolpidem tartrate on the relation of slow wave sleep and next day's glucose tolerance by PSG and OGGT in healthy volunteers.
Pharmacodynamics
PSG
glucose tolerance
AHI,3%ODI, PLMI
PVT, DSST
R-R interval, LF, HF, LF/HF, active mass
LARS, KSS, SMH
Interventional
Cross-over
Randomized
Double blind -all involved are blinded
Placebo
2
Treatment
Medicine |
oral administartion of triazolam
oral administartion of zolpidem tartrate
20 | years-old | <= |
40 | years-old | > |
Male
1)Ability to understand and willing to sign the informed consent.
2)Japanese healthy male subjects age 20 to 40 years of age
3)A body mass index(BMI)between 18 and 30 kg/m2.
4)Healthy subject as determined by medical history, physical examination, ECGs, and clinical laboratory tests.
1)Any hypersensitivities to triazolam and or zolpidem tartrate.
2)Any subject with hepatic or renal
disease requiring treatment.
3)QT prolongation over 460 ms on ECG.
4)Use of medicine, health product including Saint John's wort 7 days before pre-dose.
5)Intake of fruit food and drink including grapefruit juice, orange juice or apple juice from 7 days before pre-dose.
6)Participation to any other clinical reseach in the past 3 months.
7)Donating over 200 ml of blood in the past 1 month or over 400ml of blood in the past 3 months.
8)Positive tests of serological reaction for syphilis, HIV antigen and antibody, HBs antigen or HCV antibody.
9)Drug abuse or positive drug screening.
10)Anyone known to have a sleep disorder including insomnia, sleep apnea syndrome or restless legs syndrome in the past 3 months.
11)Use of medicine influences sleep
including hypnotic drug,psychotropic drug
or nonprescription sleep aid
in the past 3 months.
12)any subjects with abnormal glucose level or HbA1c.
13)Any condition that, in the opinion of the investigator, would make the patient unsuitable for the study.
16
1st name | |
Middle name | |
Last name | Hirokuni Tagaya |
Kitasato University
School of Allied Health Sciences
1-15-1, Kitasato, Minami-ku, Sagamihara, Kanagawa
1st name | |
Middle name | |
Last name |
Kitasato University
School of Allied Health Sciences
tagaya@kitasato-u.ac.jp
Kitasato University
MEXT
NO
2011 | Year | 10 | Month | 28 | Day |
Unpublished
Completed
2011 | Year | 10 | Month | 14 | Day |
2011 | Year | 10 | Month | 01 | Day |
2011 | Year | 10 | Month | 28 | Day |
2012 | Year | 10 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007585
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |